INCYTE CORPORATION Income Taxes Paid
INCYTE CORPORATION (INCY) reported Income Taxes Paid of -$8.79 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-04-28
- INCYTE CORPORATION income taxes paid, net for the quarter ending 2026-03-31 was -$8.79M, a 1141.11% decline year-over-year.
- INCYTE CORPORATION income taxes paid, net for the quarter ending 2025-12-31 was $26.96M, a 61.62% decline year-over-year.
- INCYTE CORPORATION income taxes paid, net for the quarter ending 2025-09-30 was $7.30M, a 90.02% decline year-over-year.
- INCYTE CORPORATION income taxes paid, net for the quarter ending 2025-06-30 was $177.07M, a 21.99% decline year-over-year.
- INCYTE CORPORATION income taxes paid, net for fiscal 2025 was $212.18M, a 43.13% decline from fiscal 2024.
- INCYTE CORPORATION income taxes paid, net for fiscal 2024 was $373.10M, a 1.35% decline from fiscal 2023.
- INCYTE CORPORATION income taxes paid, net for fiscal 2023 was $378.20M, a 177.59% increase from fiscal 2022.
- INCYTE CORPORATION income taxes paid, net for fiscal 2022 was $136.24M, a 101.15% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 9 month as first filed | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-03-31 | -$8.79M 10-Q · filed 2026-04-28 | $18.17M derived: sum of 2 quarters · filed 2026-04-28 | $25.47M derived: sum of 3 quarters · filed 2026-04-28 | $202.55M derived: sum of 4 quarters · filed 2026-04-28 | ||
| 2025-12-31 | $26.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $34.26M derived: sum of 2 quarters · filed 2026-02-10 | $211.33M derived: sum of 3 quarters · filed 2026-02-10 | $212.18M 10-K · filed 2026-02-10 | ||
| 2025-09-30 | $7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $184.38M derived: sum of 2 quarters · filed 2025-10-28 | $185.22M 10-Q · filed 2025-10-28 | $255.46M derived: sum of 4 quarters · filed 2026-04-28 | ||
| 2025-06-30 | $177.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $177.92M 10-Q · filed 2025-07-29 | $248.16M derived: sum of 3 quarters · filed 2026-04-28 | $321.35M derived: sum of 4 quarters · filed 2026-04-28 | ||
| 2025-03-31 | $844.00K 10-Q · filed 2026-04-28 | $71.08M derived: sum of 2 quarters · filed 2026-04-28 | $144.27M derived: sum of 3 quarters · filed 2026-04-28 | $371.25M derived: sum of 4 quarters · filed 2026-04-28 | ||
| 2024-12-31 | $70.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $143.43M derived: sum of 2 quarters · filed 2026-02-10 | $370.41M derived: sum of 3 quarters · filed 2026-02-10 | $373.10M 10-K · filed 2026-02-10 | $373.06M 10-K · filed 2025-02-10 | |
| 2024-09-30 | $73.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $300.17M derived: sum of 2 quarters · filed 2025-10-28 | $302.86M 10-Q · filed 2025-10-28 | $427.88M derived: sum of 4 quarters · filed 2026-02-10 | ||
| 2024-06-30 | $226.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $229.67M 10-Q · filed 2025-07-29 | $354.69M derived: sum of 3 quarters · filed 2026-02-10 | $470.56M derived: sum of 4 quarters · filed 2026-02-10 | ||
| 2024-03-31 | $2.69M 10-Q · filed 2025-04-29 | $127.71M derived: sum of 2 quarters · filed 2026-02-10 | $243.58M derived: sum of 3 quarters · filed 2026-02-10 | $373.78M derived: sum of 4 quarters · filed 2026-02-10 | ||
| 2023-12-31 | $125.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $240.89M derived: sum of 2 quarters · filed 2026-02-10 | $371.09M derived: sum of 3 quarters · filed 2026-02-10 | $378.20M 10-K · filed 2026-02-10 | $378.21M 10-K · filed 2024-02-13 | |
| 2023-09-30 | $115.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $246.07M derived: sum of 2 quarters · filed 2024-10-29 | $253.18M 10-Q · filed 2024-10-29 | $272.88M derived: sum of 4 quarters · filed 2025-02-10 | ||
| 2023-06-30 | $130.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $137.31M 10-Q · filed 2024-07-30 | $157.02M derived: sum of 3 quarters · filed 2025-02-10 | $197.09M derived: sum of 4 quarters · filed 2025-02-10 | ||
| 2023-03-31 | $7.11M 10-Q · filed 2024-04-30 | $26.81M derived: sum of 2 quarters · filed 2025-02-10 | $66.89M derived: sum of 3 quarters · filed 2025-02-10 | $139.88M derived: sum of 4 quarters · filed 2025-02-10 | ||
| 2022-12-31 | $19.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $59.78M derived: sum of 2 quarters · filed 2025-02-10 | $132.77M derived: sum of 3 quarters · filed 2025-02-10 | $136.24M 10-K · filed 2025-02-10 | ||
| 2022-09-30 | $40.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $113.06M derived: sum of 2 quarters · filed 2023-10-31 | $116.54M 10-Q · filed 2023-10-31 | $138.40M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-06-30 | $72.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $76.46M 10-Q · filed 2023-08-01 | $98.32M derived: sum of 3 quarters · filed 2024-02-13 | $108.20M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-03-31 | $3.47M 10-Q · filed 2023-05-02 | $25.33M derived: sum of 2 quarters · filed 2024-02-13 | $35.21M derived: sum of 3 quarters · filed 2024-02-13 | $70.86M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2021-12-31 | $21.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $31.73M derived: sum of 2 quarters · filed 2024-02-13 | $67.39M derived: sum of 3 quarters · filed 2024-02-13 | $67.73M 10-K · filed 2024-02-13 | ||
| 2021-09-30 | $9.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $45.53M derived: sum of 2 quarters · filed 2022-11-01 | $45.87M 10-Q · filed 2022-11-01 | $59.80M derived: sum of 4 quarters · filed 2023-02-07 | ||
| 2021-06-30 | $35.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $36.00M 10-Q · filed 2022-08-02 | $49.92M derived: sum of 3 quarters · filed 2023-02-07 | $82.54M derived: sum of 4 quarters · filed 2023-02-07 | ||
| 2021-03-31 | $339.00K 10-Q · filed 2022-05-03 | $14.26M derived: sum of 2 quarters · filed 2023-02-07 | $46.89M derived: sum of 3 quarters · filed 2023-02-07 | $70.20M derived: sum of 4 quarters · filed 2023-02-07 | ||
| 2020-12-31 | $13.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $46.55M derived: sum of 2 quarters · filed 2023-02-07 | $69.86M derived: sum of 3 quarters · filed 2023-02-07 | $70.71M 10-K · filed 2023-02-07 | ||
| 2020-09-30 | $32.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $55.93M derived: sum of 2 quarters · filed 2021-11-02 | $56.79M 10-Q · filed 2021-11-02 | $56.76M 10-Q · filed 2020-11-05 | $77.94M derived: sum of 4 quarters · filed 2022-02-08 | |
| 2020-06-30 | $23.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $24.16M 10-Q · filed 2021-08-03 | $45.32M derived: sum of 3 quarters · filed 2022-02-08 | $51.28M derived: sum of 4 quarters · filed 2022-02-08 | ||
| 2020-03-31 | $855.00K 10-Q · filed 2021-05-04 | $22.01M derived: sum of 2 quarters · filed 2022-02-08 | $27.97M derived: sum of 3 quarters · filed 2022-02-08 | $33.96M derived: sum of 4 quarters · filed 2022-02-08 | ||
| 2019-12-31 | $21.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $27.11M derived: sum of 2 quarters · filed 2022-02-08 | $33.10M derived: sum of 3 quarters · filed 2022-02-08 | $33.55M 10-K · filed 2022-02-08 | ||
| 2019-09-30 | $5.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $11.95M derived: sum of 2 quarters · filed 2020-11-05 | $12.40M 10-Q · filed 2020-11-05 | $14.88M derived: sum of 4 quarters · filed 2021-02-09 | ||
| 2019-06-30 | $5.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $6.44M 10-Q · filed 2020-08-04 | $8.92M derived: sum of 3 quarters · filed 2021-02-09 | $9.91M derived: sum of 4 quarters · filed 2021-02-09 | ||
| 2019-03-31 | $448.00K 10-Q · filed 2020-05-05 | $2.93M derived: sum of 2 quarters · filed 2021-02-09 | $3.92M derived: sum of 3 quarters · filed 2021-02-09 | $5.81M derived: sum of 4 quarters · filed 2021-02-09 | ||
| 2018-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $3.47M derived: sum of 2 quarters · filed 2021-02-09 | $5.37M derived: sum of 3 quarters · filed 2021-02-09 | $5.42M 10-K · filed 2021-02-09 | ||
| 2018-09-30 | $988.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $2.88M derived: sum of 2 quarters · filed 2019-10-29 | $2.93M 10-Q · filed 2019-10-29 | $3.05M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $1.94M 10-Q · filed 2019-07-30 | $2.06M derived: sum of 3 quarters · filed 2020-02-13 | $2.69M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-03-31 | $52.00K 10-Q · filed 2019-04-30 | $170.00K derived: sum of 2 quarters · filed 2020-02-13 | $796.00K derived: sum of 3 quarters · filed 2020-02-13 | $4.11M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2017-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $744.00K derived: sum of 2 quarters · filed 2020-02-13 | $4.06M derived: sum of 3 quarters · filed 2020-02-13 | $6.30M 10-K · filed 2020-02-13 | ||
| 2017-09-30 | $626.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $3.94M derived: sum of 2 quarters · filed 2018-10-30 | $6.19M 10-Q · filed 2018-10-30 | |||
| 2017-06-30 | $3.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $5.56M 10-Q · filed 2018-07-31 | ||||
| 2017-03-31 | $2.24M 10-Q · filed 2018-05-01 | |||||
| 2016-12-31 | $927.00K 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |